Literature DB >> 2306521

Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid less than 45 line.

C H Pui1, A J Carroll, S C Raimondi, V J Land, W M Crist, J J Shuster, D L Williams, D J Pullen, M J Borowitz, F G Behm.   

Abstract

Cytogenetic and DNA flow cytometric analyses of leukemic cells from 2,184 children with newly diagnosed acute lymphoblastic leukemia (ALL) identified 27 cases (1.2%) that had a hypodiploid line with fewer than 45 chromosomes per cell. Had cytogenetic techniques been used alone, seven cases would have been missed, compared with five if only flow cytometry had been used. For comparative purposes, the 27 cases were divided into three groups: near-haploid (n = 10), hypodiploid 30-40 (n = 9), and hypodiploid 41-44 (n = 8). Blast cells from patients with near-haploid ALL lacked structural chromosomal abnormalities; showed nonrandom retention of two copies of chromosomes 8, 10, 14, 18, 21, and the sex chromosomes; and had a second leukemic line with exactly twice the number of chromosomes or DNA content. Karyotypic analysis of the hypodiploid 30-40 and hypodiploid 41-44 groups disclosed structural abnormalities in the stemline or sideline of most of the well-banded cases; those in the latter group were similar to findings in cases with 45 chromosomes. As in the near-haploid group, chromosome 21 and the sex chromosomes were preferentially retained in the hypodiploid 30-40 and 41-44 cases. Except for a slight excess of female patients in the near-haploid group and an older age at diagnosis in the hypodiploid 30-40 cases, there were no initial clinical features that distinguished these patients from the general ALL population. Despite intensive treatment and short follow-up, 17 of the 27 patients have relapsed. This study suggests that the poor treatment responsiveness of hypodiploid ALL is not limited to the more than 80% of the patients who have 45 chromosomes per leukemic cell and demonstrates that cytogenetic and flow cytometric analyses are complementary in the evaluation of children with ALL.

Entities:  

Mesh:

Year:  1990        PMID: 2306521

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Therapeutic trials in childhood ALL: what's their future?

Authors:  O B Eden
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

2.  Array-based comparative genomic hybridization detects copy number variations with prognostic relevance in 80% of ALL with normal karyotype or failed chromosome analysis.

Authors:  V Mühlbacher; T Haferlach; W Kern; M Zenger; S Schnittger; C Haferlach
Journal:  Leukemia       Date:  2015-10-09       Impact factor: 11.528

3.  Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.

Authors:  Charles G Mullighan; Sima Jeha; Deqing Pei; Debbie Payne-Turner; Elaine Coustan-Smith; Kathryn G Roberts; Esmé Waanders; John K Choi; Xiaotu Ma; Susana C Raimondi; Yiping Fan; Wenjian Yang; Guangchun Song; Jun J Yang; Hiroto Inaba; James R Downing; Wing H Leung; W Paul Bowman; Mary V Relling; William E Evans; Jinghui Zhang; Dario Campana; Ching-Hon Pui
Journal:  Blood       Date:  2015-11-02       Impact factor: 22.113

4.  Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.

Authors:  Andrew J Carroll; Mary Shago; Fady M Mikhail; Susana C Raimondi; Betsy A Hirsch; Mignon L Loh; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; Kelly W Maloney; Leonard A Mattano; Eric C Larsen; Julie Gastier-Foster; Eileen Stonerock; Denise Ell; Samir Kahwash; Meenakshi Devidas; Richard C Harvey; I-Ming L Chen; Cheryl L Willman; Stephen P Hunger; Naomi J Winick; William L Carroll; Kathleen W Rao; Nyla A Heerema
Journal:  Cancer Genet       Date:  2019-07-30

5.  TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.

Authors:  Maoxiang Qian; Xueyuan Cao; Meenakshi Devidas; Wenjian Yang; Cheng Cheng; Yunfeng Dai; Andrew Carroll; Nyla A Heerema; Hui Zhang; Takaya Moriyama; Julie M Gastier-Foster; Heng Xu; Elizabeth Raetz; Eric Larsen; Naomi Winick; W Paul Bowman; Paul L Martin; Elaine R Mardis; Robert Fulton; Gerard Zambetti; Michael Borowitz; Brent Wood; Kim E Nichols; William L Carroll; Ching-Hon Pui; Charles G Mullighan; William E Evans; Stephen P Hunger; Mary V Relling; Mignon L Loh; Jun J Yang
Journal:  J Clin Oncol       Date:  2018-01-04       Impact factor: 44.544

Review 6.  Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui
Journal:  Front Med       Date:  2014-12-15       Impact factor: 4.592

Review 7.  Genomics in acute lymphoblastic leukaemia: insights and treatment implications.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Nat Rev Clin Oncol       Date:  2015-03-17       Impact factor: 66.675

8.  Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.

Authors:  James B Nachman; Nyla A Heerema; Harland Sather; Bruce Camitta; Erik Forestier; Christine J Harrison; Nicole Dastugue; Martin Schrappe; Ching-Hon Pui; Giuseppe Basso; Lewis B Silverman; Gritta E Janka-Schaub
Journal:  Blood       Date:  2007-05-01       Impact factor: 22.113

9.  The prognostic role of the DNA ploidy pattern in colorectal cancer analysis using paraffin-embedded tissue by an improved method.

Authors:  Y Yamazoe; S Maetani; T Nishikawa; H Onodera; T Tobe; M Imamura
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

10.  Chemotherapy versus bone marrow transplantation in childhood acute lymphoblastic leukaemia. BFM Study Group.

Authors:  W Ebell; A Reiter; H Riehm
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.